Dr. Chun-Ka Wong is Clinical Assistant Professor in Cardiology in the University of Hong Kong and Honorary Resident in Queen Mary Hospital, Hong Kong. Dr. Wong obtained Bachelor of Medicine and Bachelor of Surgery degree from the University of Hong Kong in 2015. Subsequently he received clinical and interventional cardiology training in Queen Mary Hospital. He is currently pursuing a Doctor of Philosophy degree in the University of Hong Kong. Dr. Wong’s research interests include atrial fibrillation and stem cell science. To date, he has published over 40 articles in peer reviewer journals including Circulation. 

Dr. Wong and his research team were pioneers in atrial fibrillation and cardiac rhythm diagnostics. They were the first to demonstrate feasibility of costless atrial fibrillation screening using smartphone cameras and photoplethysmography (PPG).  Furthermore, using computer vision and deep learning approaches, Dr. Wong and his team developed a smartphone application that could autonomously extract electrocardiogram (ECG) signals and deduce cardiac rhythm diagnosis from photos of ECGs taken by clinicians.  

Dr. Wong is experienced in utilizing human induced pluripotent stem cells (HiPSC) and their derived cells for disease modelling and translational therapies. At the early phase of the Coronavirus Disease 2019 (COVID-19) pandemic, Dr. Wong and his colleagues demonstrated pathogenic mechanisms of COVID-19 associated myocardial injury using HiPSC-derived cardiomyocytes and studied effect of cardiometabolic medications on disease phenotype. Currently, Dr. Wong is focusing on mechanistic studies and therapeutic strategies of newly emerged disease entities including mRNA vaccine and immune checkpoint inhibitor associated myocarditis.